Article SCOPUS
American Heart Journal  (2015)

Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

Bentley-Lewis R.; Aguilar D; Riddle M.C.; Claggett B.; Díaz R; Dickstein K.; Gerstein H.C.; Johnston P.; Køber L.V.; Lawson F.; Lewis E.F.; Maggioni A.P.; McMurray J.J.V.; PING, L; Probstfield J.L.; et. al.